John G. Stratton, Director at ABBOTT LABORATORIES (ABT), bought 2,000 shares at $86.82 ($174K) on 2026-05-07, disclosed to the SEC on 2026-06-18.
Open-market purchase of $174k ABT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ABT | BUY | 2019-02-01 | $311K | — | Filing → |